Dermata Therapeutics (DRMA) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Dermata Therapeutics (DRMA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 380K (-28.30%) | 530K (+6.00%) | 500K (-19.35%) | 620K (-51.56%) | 1.28M (-41.55%) | 2.19M (-8.75%) | 2.40M (+19.40%) | 2.01M (+25.63%) | 1.60M (+40.35%) | 1.14M (+26.67%) | 900K (+7.14%) | 840K (-29.41%) | 1.19M (+33.71%) | 890K (-42.58%) | 1.55M (-3.73%) | 1.61M (+0.63%) | 1.60M (+44.14%) | 1.11M (+38.75%) | 800K (-8.05%) | 870K (+27.94%) | 680K | - | 120K (-70.73%) | 410K | - |
Selling General And Administrative | 1.54M (+12.41%) | 1.37M (+8.73%) | 1.26M (+9.57%) | 1.15M (+8.49%) | 1.06M (+4.95%) | 1.01M (+23.17%) | 820K (-5.75%) | 870K (-45.63%) | 1.60M (+48.15%) | 1.08M (+18.68%) | 910K (+2.25%) | 890K (-18.35%) | 1.09M (+32.93%) | 820K (-7.87%) | 890K (-20.54%) | 1.12M (-5.88%) | 1.19M (-17.36%) | 1.44M (+58.24%) | 910K (+97.83%) | 460K (-70.89%) | 1.58M | - | 420K (+10.53%) | 380K | - |
Operating Expenses | 1.93M (+1.58%) | 1.90M (+7.95%) | 1.76M (-0.56%) | 1.77M (-24.36%) | 2.34M (-26.88%) | 3.20M (-0.93%) | 3.23M (+12.15%) | 2.88M (-10.00%) | 3.20M (+44.14%) | 2.22M (+22.65%) | 1.81M (+4.62%) | 1.73M (-24.12%) | 2.28M (+33.33%) | 1.71M (-30.20%) | 2.45M (-10.26%) | 2.73M (-2.15%) | 2.79M (+9.41%) | 2.55M (+49.12%) | 1.71M (+28.57%) | 1.33M (-41.15%) | 2.26M | - | 540K (-31.65%) | 790K | - |
Operating Income | |||||||||||||||||||||||||
Operating Income | -1.93M (+1.58%) | -1.90M (+7.95%) | -1.76M (-0.56%) | -1.77M (-24.36%) | -2.34M (-26.88%) | -3.20M (-0.93%) | -3.23M (+12.15%) | -2.88M (-10.00%) | -3.20M (+44.14%) | -2.22M (+22.65%) | -1.81M (+4.62%) | -1.73M (-24.12%) | -2.28M (+33.33%) | -1.71M (-30.20%) | -2.45M (-10.26%) | -2.73M (-2.15%) | -2.79M (+9.41%) | -2.55M (+49.12%) | -1.71M (+28.57%) | -1.33M (-41.15%) | -2.26M | - | -540.00K (-31.65%) | -790.00K | - |
Ebit | -1.93M (+1.58%) | -1.90M (+7.95%) | -1.76M (-0.56%) | -1.77M (-24.36%) | -2.34M (-26.88%) | -3.20M (-0.93%) | -3.23M (+12.15%) | -2.88M (-10.00%) | -3.20M (+44.14%) | -2.22M (+22.65%) | -1.81M (+4.62%) | -1.73M (-24.12%) | -2.28M (+33.33%) | -1.71M (-30.20%) | -2.45M (-10.26%) | -2.73M (-2.15%) | -2.79M (+9.41%) | -2.55M (+49.12%) | -1.71M (+28.57%) | -1.33M (-41.15%) | -2.26M (+465.00%) | -400.00K (-25.93%) | -540.00K (-31.65%) | -790.00K (-44.37%) | -1.42M |
EBITDA | -1.85M (-0.54%) | -1.86M (+10.06%) | -1.69M (-0.59%) | -1.70M (-26.09%) | -2.30M (-26.98%) | -3.15M (-0.63%) | -3.17M (+12.01%) | -2.83M (-9.58%) | -3.13M (+46.95%) | -2.13M (+23.84%) | -1.72M (+1.18%) | -1.70M (-24.11%) | -2.24M (+34.13%) | -1.67M (-30.99%) | -2.42M (-11.36%) | -2.73M (-2.15%) | -2.79M (+9.41%) | -2.55M (+49.12%) | -1.71M (+28.57%) | -1.33M (-41.15%) | -2.26M (+465.00%) | -400.00K (-25.93%) | -540.00K (-31.65%) | -790.00K (-44.37%) | -1.42M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 80K (+100.00%) | 40K (-42.86%) | 70K (0.00%) | 70K (+75.00%) | 40K (-20.00%) | 50K (0.00%) | 50K (0.00%) | 50K (-28.57%) | 70K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 40K | - | 60K (+100.00%) | 30K | - |
Net Interest Income | 80K (+100.00%) | 40K (-42.86%) | 70K (0.00%) | 70K (+75.00%) | 40K (-20.00%) | 50K (0.00%) | 50K (0.00%) | 50K (-28.57%) | 70K | - | - | - | - | - | - | - | - | - | - | - | -40.00K | - | -60.00K (+100.00%) | -30.00K | - |
Other Non Operating Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.33M | - | - | - | 790K | - |
Net Income | |||||||||||||||||||||||||
Net Income From Continuing Operations | -1.85M (-0.54%) | -1.86M (+10.06%) | -1.69M (-0.59%) | -1.70M (-26.09%) | -2.30M (-26.98%) | -3.15M (-0.63%) | -3.17M (+12.01%) | -2.83M (-9.58%) | -3.13M (+46.95%) | -2.13M (+23.84%) | -1.72M (+1.18%) | -1.70M (-24.11%) | -2.24M (+34.13%) | -1.67M (-30.99%) | -2.42M (-11.36%) | -2.73M (-2.15%) | -2.79M (+9.41%) | -2.55M (+49.12%) | -1.71M (+28.57%) | -1.33M (-42.17%) | -2.30M (+475.00%) | -400.00K (-33.33%) | -600.00K (-26.83%) | -820.00K (-42.25%) | -1.42M |
Net Income | -1.85M (-0.54%) | -1.86M (+10.06%) | -1.69M (-0.59%) | -1.70M (-26.09%) | -2.30M (-26.98%) | -3.15M (-0.63%) | -3.17M (+12.01%) | -2.83M (-9.58%) | -3.13M (+46.95%) | -2.13M (+23.84%) | -1.72M (+1.18%) | -1.70M (-24.11%) | -2.24M (+34.13%) | -1.67M (-30.99%) | -2.42M (-11.36%) | -2.73M (-2.15%) | -2.79M (+9.41%) | -2.55M (+49.12%) | -1.71M (+28.57%) | -1.33M (-42.17%) | -2.30M (+475.00%) | -400.00K (-33.33%) | -600.00K (-26.83%) | -820.00K (-42.25%) | -1.42M |
Comprehensive Income Net Of Tax | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.29M | - | - | - | - | - | - | - |